Open Access
- 22 March 2021
- journal article
- review article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 30 (R1) , R129-R137
Abstract
Globally, chronic kidney disease (CKD) represents an important non-communicable disease with significant morbidity and mortality. An estimated 10% of the world’s population had CKD in 2015 with approximately 1.2 million deaths in 2017 ( 1, 2), and the burden is expected to rise at the rate of 6% per annum ( 3, 4). By 2030, more than 70% of patients suffering from end-stage kidney disease (ESKD) worldwide will be in low and lower middle income countries of the world including African countries ( 5). Significant disparities in the burden of CKD exist worldwide, where economically disadvantaged communities, notably those on the African continent and those of the African diaspora, continue to bear a disproportionate burden of the disease ( 2, 6). This disparity is fueled by a convergence of genetic and environmental risk factors ( 7, 8). A recent meta-analysis showed an overall prevalence of CKD of 15.8% in the general population in Africa, with up to 4.6% of adults having moderate to severe kidney dysfunction ( 9). In Africa, more than 80% of the continental burden of CKD is in sub-Saharan Africa (SSA), with the highest prevalence in West Africa ( 8). The burden of CKD among African Americans, who share substantial genetic ancestry with West Africans ( 10), is similarly high; African Americans represent 13% of the USA population, but account for 35% of the patients on dialysis ( 11).Keywords
Funding Information
- Frederick National Laboratory for Cancer Research (HHSN261200800001E)
- Intramural Research Program
- National Institutes of Health
- Frederick National Laboratory
- Center for Cancer Research
- South African National Research Foundation
- Department of Health and Human Services
This publication has 97 references indexed in Scilit:
- Target Organ Damage in African American Hypertension: Role of APOL1Current Hypertension Reports, 2011
- Mapping Rare and Common Causal Alleles for Complex Human DiseasesCell, 2011
- Endosomal Localization of the Serum Resistance-Associated Protein in African Trypanosomes Confers Human InfectivityEukaryotic Cell, 2011
- The APOL1 Gene and Allograft Survival after Kidney TransplantationAmerican Journal of Transplantation, 2011
- Association of Trypanolytic ApoL1 Variants with Kidney Disease in African AmericansScience, 2010
- Characterizing the admixed African ancestry of African AmericansGenome Biology, 2009
- The Genetic Structure and History of Africans and African AmericansScience, 2009
- The apolipoprotein L family of programmed cell death and immunity genes rapidly evolved in primates at discrete sites of host–pathogen interactionsGenome Research, 2009
- MYH9 is associated with nondiabetic end-stage renal disease in African AmericansNature Genetics, 2008
- MYH9 is a major-effect risk gene for focal segmental glomerulosclerosisNature Genetics, 2008